| __timestamp | Mesoblast Limited | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 25434000 | 54823000000 |
| Thursday, January 1, 2015 | 23783000 | 76585000000 |
| Friday, January 1, 2016 | 29763000 | 87477000000 |
| Sunday, January 1, 2017 | 12065000 | 89052000000 |
| Monday, January 1, 2018 | 5508000 | 100745000000 |
| Tuesday, January 1, 2019 | 75173000 | 91915000000 |
| Wednesday, January 1, 2020 | 81497000 | 95905000000 |
| Friday, January 1, 2021 | 85731000 | 104442000000 |
| Saturday, January 1, 2022 | 63572000 | 104437000000 |
| Sunday, January 1, 2023 | 54922000 | 112009000000 |
| Monday, January 1, 2024 | 41070000 | 121134000000 |
Cracking the code
In the ever-evolving landscape of global commerce, understanding the cost of revenue is crucial for evaluating a company's financial health. Walgreens Boots Alliance, Inc., a titan in the pharmaceutical retail sector, has consistently demonstrated robust financial performance. From 2014 to 2024, its cost of revenue surged by approximately 121%, reflecting its expansive growth and market dominance. In contrast, Mesoblast Limited, a pioneering biotech firm, experienced a more volatile trajectory. Despite a peak in 2021, its cost of revenue saw a decline of around 52% by 2024, indicative of the challenges faced in the biotech industry. This comparative analysis underscores the diverse financial dynamics between established retail giants and innovative biotech companies, offering valuable insights for investors and industry analysts alike.
Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down GSK plc and Mesoblast Limited's Expenses
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for United Therapeutics Corporation and Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Perrigo Company plc
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Mesoblast Limited
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Mesoblast Limited
Analyzing Cost of Revenue: Mesoblast Limited and Taro Pharmaceutical Industries Ltd.